Lotrisone
NDC Package 0085-0809-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lotrisone is this combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0085-0809 and is authorized under FDA application NDA020010.

Identification & Billing

NDC Package Code
0085-0809-01
Package Description
1 BOTTLE, PLASTIC in 1 BOX / 30 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
00085080901
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Lotrisone
Dosage Form
-
Usage Information
This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
NDA020010
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-08-2000
End Marketing Date
06-07-2012
Listing Expiration
06-07-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-0809-01 identifies a specific commercial package of 1 bottle, plastic in 1 box / 30 ml in 1 bottle, plastic of Lotrisone, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on December 08, 2000. The current certification is valid through June 07, 2012.

What are the primary indications for this medication?

This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085080901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-0809-01
11-Digit CMS (5-4-2)
00085-0809-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.